Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells

Weiguo Zhao1, Pengtao Bao, Haowen Qi

  • 1Department of Respiratory Medicine, The Second Affiliated Hospital of Chinese PLA General Hospital, Beijing, P.R. China. zhaowg2008@qq.com

Oncology Reports
|December 4, 2009
PubMed

Insights

Resveratrol effectively combats multidrug-resistant lung cancer by inhibiting cell growth and inducing apoptosis. This natural compound also enhances chemotherapy efficacy and reduces tumor size in preclinical models.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) poses a significant therapeutic challenge.
  • Resveratrol, a natural polyphenol, has demonstrated potential anti-cancer properties.
  • Investigating resveratrol's efficacy against MDR NSCLC is crucial for developing novel treatment strategies.

Purpose of the Study:

  • To evaluate the in vitro and in vivo effects of resveratrol on multidrug-resistant human non-small cell lung cancer (NSCLC) cells (SPC-A-1/CDDP).
  • To determine resveratrol's impact on cell proliferation, apoptosis, cell cycle, chemosensitivity, and tumor growth.
  • To elucidate the role of survivin expression in resveratrol-mediated anti-cancer effects.

Main Methods:

  • In vitro treatment of SPC-A-1/CDDP cells with varying concentrations of resveratrol.
  • In vivo studies using nude mice xenograft models implanted with SPC-A-1/CDDP cells, treated with resveratrol orally.
  • Assessment of cell proliferation, apoptosis, cell cycle distribution, drug IC50 values, tumor volume, and survivin expression.

Main Results:

  • Resveratrol significantly inhibited SPC-A-1/CDDP cell proliferation and induced apoptosis in a dose- and time-dependent manner.
  • Resveratrol treatment led to cell cycle arrest at G0-G1 and G2/M phases.
  • Resveratrol decreased the IC50 values of cisplatin, gefitinib, and paclitaxel, indicating enhanced chemosensitivity, and reduced tumor volume in vivo.
  • Resveratrol downregulated survivin expression in a dose-dependent manner, correlating with apoptosis induction.

Conclusions:

  • Resveratrol exhibits significant anti-proliferative and pro-apoptotic effects against multidrug-resistant human NSCLC cells.
  • Resveratrol enhances the efficacy of conventional chemotherapeutic agents and possesses anti-tumor activity in vivo.
  • Downregulation of survivin expression is a key mechanism by which resveratrol induces apoptosis in MDR NSCLC.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...